iRhythm advances cardiac monitoring provision with $287.5m VitalConnect acquisition
IRhythm has agreed to acquire VitalConnect in a $287.5m deal positioned to expand its cardiac monitoring platform across ambulatory, inpatient,…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Philips broadens patient monitoring capabilities with six new partnerships
Philips is broadening its patient monitoring ecosystem’s range of wearable and out-of-hospital monitoring technologies through a raft of new partnerships.…
-
Medtronic’s ablation system lands ventricular arrhythmia indication expansion in Europe
Medtronic’s Sphere-9 catheter and Affera mapping and ablation system has secured a CE mark in Europe for ventricular arrhythmia treatment.…
-
BlueWind Medical lands FDA clearance for UUI implant with 15-year lifespan
BlueWind Medical’s Revi Extend, the company’s next-generation urge urinary incontinence (UUI) treatment that extends the implant’s lifespan to 15 years,…
-
Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook
Zimmer Biomet has reported Q2 revenues of around $2.18bn, denoting a year-over-year (YoY) uptick of 4.8%, and a revised full…
-
Podcast: RevealDx’s CEO on the global radiologist shortage
The radiology space continues to face practitioner shortages that are contributing towards burnout and bottlenecks globally. A 2023 report by…
-
Wellinks secures $10m for respiratory disease RPM tool’s advancement
Wellinks has raised $10m to advance its remote patient monitoring (RPM) tool for chronic respiratory disease management. The first close…
-
Prevention will only work if NHS digitilsation is built on infrastructure patients and clinicians can trust
Steve Sanghera, CEO of Inventus, outlines what factors need the utmost consideration if digitalisation plans within the UK NHS are going…
-
Galaxy Therapeutics secures CE mark for embolisation system
Galaxy Therapeutics has secured a CE mark for its saccular endovascular aneurysm lattice (SEAL) embolisation system and is now preparing…
-
GE HealthCare expands breast imaging portfolio with launch of new product duo
GE HealthCare is expanding its breast imaging portfolio with the launch of a duo of new solutions that are respectively…